S

Sientra Inc
F:S0Z

Watchlist Manager
Sientra Inc
F:S0Z
Watchlist
Price: 1.302 EUR -3.41%
Market Cap: 206.4m EUR

Operating Margin

-72.2%
Current
Improving
by 1.6%
vs 3-y average of -73.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-72.2%
=
Operating Income
$-55.6m
/
Revenue
$90.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-72.2%
=
Operating Income
€-55.6m
/
Revenue
$90.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Sientra Inc
F:S0Z
206.4m EUR
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
32.2B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.1B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
124B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.2B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.7B CNY
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.9B USD
Loading...
No Stocks Found

Market Distribution

Lower than 83% of companies in the United States of America
Percentile
17th
Based on 14 112 companies
17th percentile
-72.2%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Sientra Inc
Glance View

Market Cap
206.4m EUR
Industry
Health Care

Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Santa Barbara, California and currently employs 319 full-time employees. The company went IPO on 2014-10-29. The firm's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The firm sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The firm also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.

S0Z Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-72.2%
=
Operating Income
$-55.6m
/
Revenue
$90.3m
What is Sientra Inc's current Operating Margin?

The current Operating Margin for Sientra Inc is -72.2%, which is above its 3-year median of -73.8%.

How has Operating Margin changed over time?

Over the last 3 years, Sientra Inc’s Operating Margin has increased from -95.6% to -72.2%. During this period, it reached a low of -104.4% on Dec 31, 2020 and a high of -64.9% on Sep 30, 2022.

Back to Top